“Faulty Testimony Sent 2 to Death Row, Panel Finds”: The New York Times today contains an article that begins, “Faulty evidence masquerading as science sent two men to death row for arson in Texas and led to the execution of one of them, a panel of private fire investigators concluded in a report released Tuesday in Austin.”
The Chicago Tribune today contains an article headlined “Report: Inmate wrongly executed; Arson experts say evidence in Texas case scientifically invalid.”
In The Los Angeles Times, Henry Weinstein reports that “Panel Says Faulty Arson Evidence Led to Execution; A man was convicted of murdering his three children based on ‘bad science,’ its report says.”
The Austin American-Statesman reports that “Texan executed on invalid evidence, experts say; Arson ruled out in fatal fire, report by Innocence Project concludes.”
The Houston Chronicle reports that “Arson experts cite bad evidence in ’04 execution; Report sought by the Innocence Project says fires were accidental.”
The Dallas Morning News contains an article headlined “Was an innocent man put to death? Obsolete science led to arson conviction, center says; case reviews urged.”
And The Fort Worth Star-Telegram reports that “Executed man’s case challenged.”
“Trouble Finding Inmate’s Vein Slows Lethal Injection in Ohio”: Adam Liptak has this article today in The New York Times.
The Cleveland Plain Dealer reports today that “Condemned killer complains lethal injection ‘isn’t working’; Ohio’s executioners struggle 40 minutes to find a working vein.”
And The Columbus Dispatch contains an article headlined “‘It don’t work,’ inmate says during botched execution.”
“RIM faces tough challenger in Visto”: The Toronto Globe and Mail today contains an article that begins, “Visto Corp. may be a tougher legal opponent for Research In Motion Ltd. than the last firm that tried to shut down BlackBerry wireless operations in the United States.”
“Lay Wraps Up His Testimony; Enron Founder Calls Bankruptcy ‘Most Painful Thing’ in Life”: This article appears today in The Washington Post.
The Los Angeles Times reports today that “Enron’s Former Chief Concludes Testimony; Kenneth Lay tries to undo damage done last week when a prosecutor revealed that Lay tried to contact witnesses.”
The New York Times contains a news analysis headlined “Did Ken Lay Demonstrate Credibility?”
The Wall Street Journal reports that “Lay Defends His Business Practices At Enron Trial” (free access).
USA Today reports that “Lay says he loved Enron, workers; Prosecution raises $70 million in stock sales again.”
And The Houston Chronicle contains articles headlined “Lay ends testimony saying he loved his company, workers; His 90 minutes on the stand cap six days in which exchanges often got contentious“; “Lawyers who saw Lay testify say abrasive way is ill-advised; One observer compares former Enron chairman to Richard Nixon“; and “Lay’s attorney back in the hospital.”
“Deliberations on Moussaoui’s Fate Enter 7th Day”: Neil A. Lewis has this article today in The New York Times.
The Washington Post reports today that “35 Hours of Discussion By Moussaoui Jurors Considered Lengthy.”
And The Los Angeles Times reports that “Moussaoui Jury Enters Day 7; Speculation grows that the panel is unable to agree on whether the admitted Sept. 11 conspirator should get the death penalty.”
“Malvo Reportedly Seeking Plea Deal in Sniper Trial”: This article appears today in The Washington Post.
And The Baltimore Sun reports today that “Sniper could face Malvo; Prosecutors seek deal that would put Muhammad’s companion on stand.”
“Let the people see the court”: The Chicago Tribune today contains an editorial that begins, “In February, the Supreme Court missed a great chance to expand popular interest in law.”
“Mexico to Allow Use of Drugs; Fox will sign the bill, one of the world’s most permissive policies, in a bid to curb trafficking; U.S. officials say it will lead to more addiction”: The Los Angeles Times today contains an article that begins, “Mexican President Vicente Fox will sign a bill that would legalize the use of nearly every drug and narcotic sold by the same Mexican cartels he’s vowed to fight during his five years in office, a spokesman said Tuesday.”
The Chicago Tribune reports today that “U.S. critics try to smoke out clarity on Mexican drug bill.”
And The San Antonio Express-News reports that “Mexico vows it won’t become ‘a paradise for drug users.’”
“Court Backs Experimental Drugs for Dying Patients”: This article appears today in The Washington Post, along with an editorial entitled “A Court Makes Up a Right; The Founding Fathers and the FDA.” My earlier coverage appears here.
“An Unqualified Judicial Nominee”: The New York Times today contains an editorial that begins, “Senate Republicans have announced plans to push for a quick vote on Brett Kavanaugh, whose nomination for a powerful appeals court judgeship has languished since 2003.”
And online at The American Spectator, Quin Hillyer has an essay entitled “Here Come Da Judge.”
“Judge Boyle ruled fairly in GE case”: This letter to the editor appears today in The News & Observer of Raleigh, North Carolina.
“How to influence judges”: Today’s edition of USA Today contains an editorial that begins, “Members of Congress aren’t the only public officials who take lavish trips paid for by special interests with stakes in their decisions. Federal judges accept junkets, too. They’re just better at keeping it quiet.”
“No Way Out — Trapped by Rules, The Mentally Ill Languish in Prison; For Such Felons, Parole Is Rare, Recidivism Is Probable; Lack of State Hospitals; ‘It Scares the Hell Out of Me'”: This front page article (free access) appears today in The Wall Street Journal.
“Sins of Omission: Why the Ninth Circuit Was Wrong to Excuse a Lack of Police Diligence.” FindLaw commentator Sherry F. Colb has this essay today.
